Document
IPR2023-00724, No. 2478 Exhibit - EX2478 Chen, J, Blockbuster Drug What it is, How it works, Investopedia, httpswwwinvestopediacomtermsbblockbuster drugasp, last updated Sept 6, 2022 (P...
Cite Document
IPR2023-00724, No. 2478 Exhibit - EX2478 Chen, J, Blockbuster Drug What it is, How it works, Investopedia, httpswwwinvestopediacomtermsbblockbuster drugasp, last updated Sept 6, 2022 (P.T.A.B. Jan.
+ More Snippets
Document
IPR2023-00724, No. 2531 Exhibit - EX2531 Invokamet and Invokamet XR Prescribing Information rev July 2023 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2531 Exhibit - EX2531 Invokamet and Invokamet XR Prescribing Information rev July 2023 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1058 Exhibit - Blonde 2012 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1058 Exhibit - Blonde 2012 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1104 Exhibit - Exhibit 1104 Vahl (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1104 Exhibit - Exhibit 1104 Vahl (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1314 Exhibit - Exhibit 1314 Redacted Vellturo Dep (P.T.A.B. Jun. 21, 2024)
Cite Document
IPR2023-00724, No. 1314 Exhibit - Exhibit 1314 Redacted Vellturo Dep (P.T.A.B. Jun. 21, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2508 Exhibit - EX2508 Novo Nordisk, Financial report for the period 1 January 2021 to 30 September 2021 Nov 3, 2021 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2508 Exhibit - EX2508 Novo Nordisk, Financial report for the period 1 January 2021 to 30 September 2021 Nov 3, 2021 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2019 Exhibit - EX2019 Transcript of January 5, 2024 Deposition of William J Jusko, PhD (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2019 Exhibit - EX2019 Transcript of January 5, 2024 Deposition of William J Jusko, PhD (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2458 Exhibit - EX2458 US Food Drug Administration, DrugsFDA, Soliqua 10033 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2458 Exhibit - EX2458 US Food Drug Administration, DrugsFDA, Soliqua 10033 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2020 Exhibit - EX2020 Transcript of January 5, 2024 Deposition of William J Jusko, PhD (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2020 Exhibit - EX2020 Transcript of January 5, 2024 Deposition of William J Jusko, PhD (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2538 Exhibit - EX2538 Excerpt of Opening Expert Report of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335, 462, In re Ozempic Semag lutide Patent Litigation, N...
Cite Document
IPR2023-00724, No. 2538 Exhibit - EX2538 Excerpt of Opening Expert Report of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335, 462, In re Ozempic Semag lutide Patent Litigation, No 122 cv 0
+ More Snippets
Document
IPR2023-00724, No. 1312 Exhibit - Exhibit 1312 Redacted Jensen Dep (P.T.A.B. Jun. 21, 2024)
Cite Document
IPR2023-00724, No. 1312 Exhibit - Exhibit 1312 Redacted Jensen Dep (P.T.A.B. Jun. 21, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1150 Exhibit - Exhibit 1150 Park 2007 (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1150 Exhibit - Exhibit 1150 Park 2007 (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1184 Exhibit - Exhibit 1184 (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1184 Exhibit - Exhibit 1184 (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1177 Exhibit - Exhibit 1177 Novo Nordisk Annual Report 2023 (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1177 Exhibit - Exhibit 1177 Novo Nordisk Annual Report 2023 (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1180 Exhibit - Exhibit 1180 David and Stewart (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1180 Exhibit - Exhibit 1180 David and Stewart (P.T.A.B. May. 22, 2024)
+ More Snippets